Takeda Reports First Half FY2016 Results And Raises Full Year Profit Guidance

OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502):

Strong first half results led by Growth Drivers

• Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets). Reported revenue declined -5.9%, due to unfavorable currencies (-8.6pt) and the impact of divestitures (-4.7pt).